Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.

Patricia MarañónCarlos Ernesto Fernández-GarcíaStephania C IsazaEsther ReyRocío Gallego-DuránRocío Montero-VallejoJavier Rodríguez de CíaJavier AmpueroManuel Romero-GómezCarmelo García-MonzónÁgueda González-Rodríguez

Published in: Biomarker research (2022)

This proof-of-concept study shows BMP2 as a new molecular target linked to NAFLD and introduces SAN as a simple and efficient algorithm to screen individuals at risk for NASH.

Keyphrases

machine learning
mesenchymal stem cells
high throughput
deep learning
single molecule
risk assessment
bone marrow